Novo Nordisk's semaglutide ... Semaglutide is also being developed as a once-weekly injection that has already been shown to provide good control of blood glucose in phase III trials, with ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...